Are There Clinical Trials Studying Cannabis for OCD?

PostedFebruary 27, 2026

UpdatedFebruary 27, 2026

ByMy Patient Advice

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Ongoing CBD research for OCD is exploring the potential of cannabinoids to reduce compulsions and intrusive thoughts. Clinical studies aim to evaluate safety, dosage, and therapeutic outcomes.

Understanding Clinical Investigations

Current CBD research for OCD includes cannabidiol trials for OCD that examine the efficacy of CBD alone or in combination with THC for symptom management.

Study Design and Participants

Trials often include adults diagnosed with OCD, with careful monitoring of symptom severity, side effects, and functional improvements.

Evaluating Effectiveness

Researchers focus on CBD effectiveness by measuring changes in anxiety, compulsive behaviours, and overall quality of life before and after treatment.

Evidence for CBD Therapy

Emerging data from these studies contributes to CBD therapy evidence for OCD, guiding safe and informed use for patients considering cannabinoid treatment.

Future Research Directions

Further trials are needed to determine optimal dosing, long-term effects, and the comparative benefits of CBD versus traditional OCD treatments.

With ongoing CBD research for OCD, clinicians and patients can make evidence-informed decisions about integrating cannabinoids into care plans to potentially alleviate OCD symptoms safely and effectively.

If you’re exploring cannabis treatment options for obsessive-compulsive disorder, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and Obsessive-Compulsive Disorder.

Julia Sutton, MSc

Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Clarissa Morton, PharmD

Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.